Coronavirus company news summary – Seegene to provide ten million Covid-19 tests to Brazil – 1-Drop receives FDA’s EUA for Covid-19 test kit

19 May 2020 (Last Updated May 19th, 2020 09:32)

South Korean company Seegene will supply ten million Covid-19 testing kits to Pan American Health Organization (PAHO) / World Health Organization (WHO) via Seegene do Brasil Diagnosticos, its Brazilian subsidiary. So far, the company has exported five million tests of Allplex 2019-nCOV assay to Brazil and the remaining five million will be supplied in the coming weeks. Seegene also plans to scale up its testing volume by up to 100%.

Gold Standard Diagnostics has announced the Emergency Use Authorization (EUA) submission of a Multiplex Real-Time, reverse-transcriptase polymerase chain reaction (RT-PCR) assay to detect the presence of Covid-19 causing SARS-CoV-2 virus. The assay is available in the US for purchase. The GSD NovaPrime SARS-CoV-2 (COVID-19) assay can simultaneously detect the two target sequences inside the N gene.

Kahala Biosciences and Rymedi have launched the ADIONA Covid-19 antibody testing platform. This platform is the first in the US that combines antibody testing with a blockchain-based smartphone software application, and claims to bring predictability and traceability to Covid-19 antibody testing. It combines a rapid point-of-care antibody (IgG/IgM) test carried out using a finger stick with an end-to-end blockchain solution.

South Korean coronavirus test kit maker 1-Drop has received EUA from US Food and Drug Administration (FDA) for its Covid-19 qPCR Multi Kit. With this approval, 1-Drop will be the sixth South Korean company to receive the EUA from the FDA. The company plans to boost the expansion to the North American market.